HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yaowei Zhu Selected Research

Isoenzymes

11/2020Evaluating Potential Disease-Mediated Protein-Drug Interactions in Patients With Moderate-to-Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yaowei Zhu Research Topics

Disease

13Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 12/2004
3Body Weight (Weight, Body)
04/2013 - 02/2009
1Neoplasms (Cancer)
12/2021
1Psoriatic Arthritis
12/2015
1Tetanus
06/2010
1Multiple Sclerosis
06/2010
1Rheumatoid Arthritis
05/2006

Drug/Important Bio-Agent (IBA)

8Monoclonal AntibodiesIBA
01/2021 - 12/2004
8Ustekinumab (CNTO 1275)FDA Link
01/2021 - 02/2009
6Interleukin-12 (IL 12)IBA
04/2013 - 12/2004
3guselkumabIBA
11/2020 - 01/2018
3Immunoglobulins (Immunoglobulin)IBA
04/2013 - 03/2010
2Prostaglandins AIBA
01/2021 - 10/2015
2Interleukin-23 (Interleukin 23)IBA
01/2018 - 03/2010
110-hydroxycamptothecinIBA
12/2021
1MicellesIBA
12/2021
1homocamptothecinIBA
12/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2021
1Cytochrome P-450 CYP2C19IBA
11/2020
1IsoenzymesIBA
11/2020
1Proteins (Proteins, Gene)FDA Link
11/2020
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
11/2020
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
11/2020
1Cytochrome P-450 CYP3AIBA
11/2020
1Cytochrome P-450 CYP2C9IBA
11/2020
1C-Reactive ProteinIBA
12/2015
1InterleukinsIBA
06/2010
1AntigensIBA
06/2010
1AntibodiesIBA
02/2009
1Messenger RNA (mRNA)IBA
05/2007
1Interleukin-8 (Interleukin 8)IBA
05/2007
1Interleukin-18 (Interleukin 18)IBA
05/2007
1Infliximab (Remicade)FDA Link
05/2006
1Methotrexate (Mexate)FDA LinkGeneric
05/2006

Therapy/Procedure

3Therapeutics
12/2021 - 10/2015